enGene to Participate in Upcoming Investor Conferences
Article content
Article content
Article content
BOSTON & MONTREAL — enGene Holdings Inc. (Nasdaq: ENGN or 'enGene' or the 'Company'), a clinical-stage, non-viral genetic medicines company, today announced that management will present at upcoming investor conferences in May 2025. Details of the conferences are below:
Article content
Conference: 2025 Bloom Burton & Co. Healthcare Investor Conference
Date: Monday, May 5, 2025
Time: 2:30 p.m. ET
Format: Corporate Presentation
Article content
Conference: The Citizens Life Sciences Conference
Date: Wednesday, May 7, 2025
Time: 11:30 a.m. ET
Format: Fireside Chat
Article content
Article content
A live webcast of these presentations can be accessed under the 'Investors' section of the enGene website at www.engene.com and will be archived there for 90 days.
Article content
enGene is a clinical-stage biotechnology company mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs. enGene's lead program is detalimogene voraplasmid (also known as detalimogene, and previously EG-70) for patients with Non-Muscle Invasive Bladder Cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 study, which includes a pivotal cohort studying detalimogene in Bacillus Calmette-Guérin (BCG)-unresponsive patients with carcinoma in situ (CIS). Detalimogene was developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA.
Article content
Article content
Article content
Article content
Contacts
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
43 minutes ago
- Globe and Mail
Palantir Stock Soars 69% Year to Date: Time to Hold or Chase?
Palantir Technologies Inc. PLTR has surged 69% year to date, eclipsing the industry 's modest 13% average and outshining heavyweights like Nvidia NVDA and Oracle ORCL. Nvidia, a leading force in AI and graphics processing technology, has recorded a 6% gain so far this year. Similarly, Oracle, renowned for its enterprise software and cloud infrastructure services, has gained 5% year to date. In a macroeconomic landscape that has left many tech giants limping, Palantir's relentless rally stands out, but does this pace leave any meaningful upside for new investors? While Nvidia continues wrestling with cyclical demand and Oracle faces pressure on its cloud transition pace, Palantir is thriving by doubling down on artificial intelligence and data-centric enterprise software. The key question now: Is this AI darling still a buy, or has the market already priced in perfection? Explosive AIP Adoption Fuels PLTR's Growth The backbone of Palantir's recent success is its Artificial Intelligence Platform (AIP), which is rapidly transforming into the company's biggest commercial catalyst. U.S. commercial revenues skyrocketed 71% year over year and 19% sequentially in the first quarter of 2025, pushing the annual run rate past the $1 billion mark for the first time. Total contract value in this segment skyrocketed 239% YoY, with deal sizes proliferating, more than double the number of $1 million contracts closed compared to last year. The rising popularity of AIP bootcamps — short, targeted training sessions for enterprise AI deployment — is a major driver. These bootcamps reduce implementation timelines and showcase AIP's plug-and-play value, helping customers scale AI operations faster than ever. Palantir's flexible, modular sales model allows clients to start small with specific components, further lowering adoption friction. Combined with usage-based pricing, this strategy has broadened Palantir's reach in the U.S. commercial sector, making AI integration more accessible and scalable for new clients. PLTR's Balance Sheet Strength Bolsters Confidence As of March 31, 2025, Palantir boasted $5.4 billion in cash and no debt. This fortress balance sheet gives the company strategic flexibility to reinvest in growth without external financing pressures. Revenue growth remains robust—first quarter sales soared 39.3% YoY. Deal momentum is equally encouraging with Palantir closing 139 deals of at least $1 million, 51 deals of at least $5 million and 31 deals of at least $10 million in the quarter. PLTR's Earnings Momentum Remains Strong The Zacks Consensus Estimate for second-quarter 2025 EPS stands at 14 cents, up 55.6% from a year ago. Full-year earnings are projected to grow 44% in 2025 and 25% in 2026. Sales estimates are equally bullish, with 38% expected growth in the second quarter and full-year top-line increases of 37% and 28% for 2025 and 2026, respectively. Valuation: Palantir's Biggest Headwind Despite its strong fundamentals, PLTR's valuation is hard to ignore. Its forward P/E ratio of 197 dwarfs the industry average of 40. This lofty premium reflects high expectations around future AI monetization and government contracts. While the growth story is compelling, the stock is priced for near-flawless execution, leaving minimal margin for error. Such a valuation exposes the stock to heightened volatility, especially if earnings or guidance falter in any quarter. Investors must weigh long-term promise against short-term risk. Verdict: Hold Your Ground, Don't Overextend Palantir is proving itself as a real contender in AI-powered enterprise solutions. It has the momentum, the product-market fit, and the financial strength to keep growing. But the current price likely already reflects much of this optimism. While long-term investors should hold onto their positions, chasing the stock at these levels could prove risky. A better entry point may emerge after a pullback and valuation reset. PLTR currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Zacks Names #1 Semiconductor Stock It's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom. With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028. See This Stock Now for Free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NVIDIA Corporation (NVDA): Free Stock Analysis Report Oracle Corporation (ORCL): Free Stock Analysis Report Palantir Technologies Inc. (PLTR): Free Stock Analysis Report This article originally published on Zacks Investment Research (
Globe and Mail
3 hours ago
- Globe and Mail
Intel's Dual Gamble: AI Innovation Now, Foundry Fortunes Later?
[content-module:CompanyOverview|NASDAQ:INTC] Intel Corporation (NASDAQ: INTC) continues pursuing a demanding dual strategy to revitalize its market standing and financial health. The company's stock price is hovering near $20.25 in early June 2025, reflecting a significant investor evaluation of its turnaround prospects. The company's turnaround strategy hinges on successfully balancing two core imperatives. First, Intel must drive rapid innovation and capture immediate market share in artificial intelligence (AI)-powered client and data center products. Second, Intel must complete its current Foundry business undertaking and become a global player in contract chip manufacturing. The effective management of these distinct yet interconnected ambitions is the most critical factor that could reshape Intel's market position and ultimately enhance shareholder value. The AI Engine: Intel's Bid for Immediate Product Wins Intel's immediate focus on integrating artificial intelligence across its key product lines is designed to generate quicker financial returns and demonstrate market leadership. Success in this arena could provide vital momentum and resources while its longer-term foundry ambitions continue to mature. In the Client Computing Group (CCG), Intel is aggressively targeting the burgeoning AI PC market. Key initiatives include: Product Pipeline: Leveraging its Core Ultra processors and advancing a roadmap that features Panther Lake, Lunar Lake, Arrow Lake, and newly outlined CPUs like Nova Lake-S/U, Wildcat Lake, and Bartlett Lake-S. Market Target: A stated goal of shipping over 100 million AI PCs by the end of 2025. Financial Potential: This AI PC push could increase Average Selling Prices (ASPs) and improve profit margins for the CCG segment, which recorded $7.6 billion in revenue in Q1 2025. Within the Data Center and AI (DCAI) segment, Intel is also making strides: Key Offerings: The rollout of new Xeon 6 processors and Gaudi 3 AI accelerators aims to strengthen Intel's competitive position against rivals in the high-growth AI infrastructure market. Performance Metrics: The DCAI segment showed positive momentum with $4.1 billion in revenue in Q1 2025, an 8% year-over-year increase. Strong market adoption and financial performance from these AI-centric products could offer significant near-term catalysts for Intel's stock, potentially alleviating some investor concerns stemming from the high costs associated with its foundry development strategy. Intel's Foundry Bet: High Stakes, High Rewards Parallel to its AI product drive, Intel is pursuing the transformative, multi-year goal of establishing Intel Foundry as a world-leading contract manufacturer, a cornerstone of its IDM 2.0 strategy. This endeavor is crucial for Intel's long-term competitive positioning but comes with substantial financial commitments and execution risks. Key aspects of this long-term strategy include: Technological Reclamation: The "five nodes in four years" roadmap is central to regaining leadership in the manufacturing process. The Intel 18A node, which entered risk production in April 2025 and features advanced RibbonFET transistors and PowerVia backside power delivery, is a critical test. The new Panther Lake CPUs are slated to be its first products, and their release is anticipated in the second half of 2025. Building Credibility and Business: Securing commitments from major external customers is paramount. Microsoft (NASDAQ: MSFT) has already committed to using Intel 18A for a future chip design, and a partnership with Amazon Web Services covers Intel 3 and 18A nodes. These are vital early endorsements. The Financial Hurdle: The foundry segment currently operates at a significant loss, reporting a $2.3 billion operating deficit in Q1 2025. Intel is targeting break-even status for this division by 2027, a crucial milestone given the $18 billion gross capital expenditure target for 2025. Furthermore, Intel Foundry must "earn" business from Intel's product divisions, a dynamic intended to ensure its competitiveness against external foundries like TSMC. This foundry venture's perceived risks and eventual payoff heavily influence investor sentiment towards Intel's stock. Demonstrable progress in technology, customer acquisition, and a clear path to profitability are essential long-term drivers for the stock. Gauging Risks and Rewards in Intel's Dual Strategy [content-module:Forecast|NASDAQ:INTC] Intel's dual strategy, while ambitious, presents a compelling risk/reward scenario for investors. With the stock trading near its 52-week low and a cautious analyst consensus, much of the market's skepticism appears to be priced in. This environment potentially offers an attractive entry point for long-term investors, particularly considering upcoming catalysts such as the Panther Lake CPU launch in late 2025. While execution risks persist in product innovation and foundry development, the potential upside is considerable. Intel's strategic push into high-growth AI segments aims to bolster its near-term financial performance. These gains can, in turn, support the capital-intensive build-out of Intel Foundry, which benefits from government incentives and a global need for diversified chip manufacturing. This potential is supported by Intel's sizable asset base, reflected in a price-to-book ratio (P/B) of approximately 0.83. Investors should monitor key indicators for positive momentum: Stronger AI product sales and margin improvements. New high-volume foundry customer wins and clear progress on the Intel 18A manufacturing ramp. A steady climb in overall gross margins from the current Q2 non-GAAP guidance of ~36.5% towards the company's +50% target. Successfully hitting these markers could significantly shift the current market narrative, suggesting Intel has the resources and strategy to achieve its objectives and deliver notable long-term shareholder value. Intel's Need for Tangible Results [content-module:TradingView|NASDAQ:INTC] Intel's journey to redefine its market position and deliver enhanced shareholder value is intricately tied to its ability to execute its dual mandate flawlessly. Near-term successes in the AI PC and data center markets, driven by compelling product innovation, are essential for immediate financial health. They build confidence and provide the resources needed for the longer, more arduous path of establishing a globally competitive and profitable foundry business. Ultimately, consistent and tangible results across both these strategic fronts will be the decisive factor in Intel's turnaround and its ability to reward patient investors. Where Should You Invest $1,000 Right Now? Before you make your next trade, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list. They believe these five stocks are the five best companies for investors to buy now...
The Market Online
4 hours ago
- The Market Online
Microsoft unveils new handheld console. Too little, too late in the game?
Microsoft (NASDAQ:MSFT) has officially entered the handheld gaming arena with the reveal of the ROG Xbox Ally, a portable console The announcement comes just three days after Nintendo (OTC Pink:NTDOF) launched the Switch 2 console The device is slated for release at the end of 2025, though Microsoft has yet to disclose pricing details Microsoft stock (NASDAQ:MSFT) opened trading at US$470.46 After years of speculation and abandoned prototypes, Microsoft (NASDAQ:MSFT) has officially entered the handheld gaming arena with the reveal of the ROG Xbox Ally (pictured above), a portable console developed in partnership with Asus. The announcement marks a significant milestone for the tech giant, which has long been rumored to be working on a handheld Xbox device. The ROG Xbox Ally is designed to give gamers full access to their Game Pass subscription library on-the-go, effectively launching with a catalog of hundreds of titles. This native integration with Game Pass could be a game-changer for Microsoft's 34 million subscribers, offering a seamless way to continue their gaming experience beyond the living room. Asus, known for its ROG (Republic of Gamers) brand, brings its expertise in handheld gaming hardware to the table. Since 2023, the company has been refining its portable gaming devices, and the ROG Xbox Ally appears to be the culmination of that experience, now backed by Microsoft's software ecosystem. The device is slated for release at the end of 2025, though Microsoft has yet to disclose pricing details. The announcement comes just three days after Nintendo (OTC Pink:NTDOF) launched the Switch 2 console, a hybrid console that continues the legacy of its predecessor by offering both portable and docked play modes. The timing of Microsoft's reveal is notable. The Switch 2's early success has reaffirmed the demand for hybrid and handheld gaming, a trend that also inspired the development of Valve's Steam Deck. That device, a handheld PC, allows users to access their Steam libraries on the go—though compatibility issues with certain titles have been a sticking point. Microsoft's entry into this space raises a compelling question: Is it too late to the game? With established competitors already thriving, the ROG Xbox Ally faces a steep climb. However, its native Game Pass support—a feature neither the Switch 2 nor the Steam Deck can offer—may be the key to carving out a strong foothold in the market. As the holiday season approaches and more details emerge, all eyes will be on how Microsoft positions the ROG Xbox Ally in a rapidly evolving handheld gaming landscape. About Microsoft Microsoft Corp. develops and supports software, services, devices and solutions. The company's segments include productivity and business processes, intelligent cloud and more personal computing. Microsoft stock (NASDAQ:MSFT) opened trading 8 cents higher at US$470.46 and has levelled up 10.02 per cent since this time last year. Join the discussion: Find out what everybody's saying about this stock on the Microsoft Corp. Bullboard investor discussion forum, and check out the rest of Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
